• No results found

Professional Product List 2016

N/A
N/A
Protected

Academic year: 2021

Share "Professional Product List 2016"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

(1)

Trade diagnostical products

for clinical laboratories

products for life.

Professional Product List

2016

CLINICAL CHEMISTRY Occupational

Medicine

Drugs of Abuse

TDM

High Diagnostic Sensitivity and Specificity - Easily adaptable to most common automated Open Systems - Colour-Coded kit reagents for easy recognition - Economical Benefit - Controls and Calibrators included -

24 Month shelf life

Test diagnostici in vitro ad alta specificità e sensibilità dedicati alla Medicina del Lavoro, monitoraggio farmaci e rilevazione Droghe d’Abuso.

(2)
(3)

Indice - Index

PRODUCT NAME

PAGE

MEDICINA DEL LAVORO - OCCUPATIONAL MEDICINE

3

DROGHE D’ABUSO - DRUGS of ABUSE TEST - DOA

4

MONITORAGGIO FARMACI - THERAPEUTIC DRUG

MONITORING - TDM

5

(4)

PRODUCT NAME

REF

PACKAGING

OCCUPATIONAL MEDICINE

AAP Urine

Colorimetric 7002 12x6 mL

ACE UV Liquid

Fixed Time 7005 4x20 mL

ALA Dehydrase

Colorimetric 3602 50 Tests

ALCOHOL Ethanol Liquid

Enzymatic Endpoint UNIVERSAL 7157 4x25 mL

AMMONIA

Enzymatic U.V. - Monoreagente BXC0376 R1: 10x10 mL

AMYLASE PANCREATIC

IFCC dual reagent liquid BXC0564A R1: 5x10 mL R2: 5x2 mL

CARBOXYHEMOGLOBIN

Enzymatic UV 3697 5x5 mL

CITRIC ACID

Enzymatic UV 7046 5x20 mL

HIPPURIC ACID

Colorimetric 3610 100 Test

HYDROXYPROLINE

Colorimetric 7162 10x3 Test

LACTATE Liquid

Colorimetric 7170 5x25 mL

LYSOZYME

Turbidimetric 7104 12x6 mL

METHEMOGLOBIN

Spectrophotometric 3698 25 Test

NAG

Colorimetric 7112 5x4 mL

PHENOLS

Colorimetric 3616 50 Test

TRICHLORACETIC ACID

Colorimetric 3622 100 Test

XYLOSE

Colorimetric 7152 60 Test

G6-PDH Visual

Test qualitativo di screening per rilevare la carenza della Glucosio 6 Fosfato Deidrogenasi.

Qualitative screening test for Glucose-6 Phosphate Dehydrogenase deficiency.

25936 10 Test

G6-PDH CareStart™

Test qualitativo di screening per rilevare la carenza della Glucosio 6 Fosfato Deidrogenasi.

Qualitative screening test for Glucose-6 Phosphate Dehydrogenase deficiency.

G0221 25 Card

(5)

PRODUCT NAME

REF

PACKAGING

DRUGS OF ABUSE RAPID TEST

DOA-8 Test Cup (Split type) + 2 adulterant

Test rapido per la determinazione simultanea qualitativa di 8 droghe e loro metaboliti

nell’urina, inclusi due test di validità campione (S.V.T. ) AMP 500, BUP 10,COC 300, THC 50, MTD 300, MET 500, MDMA 500,MOP 300 + PH,

Creatinine) Multi Drug Screen Panel is one-step panel immunoassay for the qualitative detection of multiple drug metabolites in human urine, collecting and Urine Check for the validation of Urine Specimen Examined.

1L26P3 10 Test

MULTI DRUG Panel 10 parametri

Test rapido per la determinazione simultanea qualitativa di 10 droghe e loro metaboliti

nell’urina umana. (AMP 500, BUP 10,COC 300, THC 50, MTD 300, MET 500, MDMA 500,MOP 300) Multi Drug Screen Panel is a lateral flow one-step panel immunoassay for the

qualitative detection of multiple drug metabolites in human urine

1L26M3 25 Card

ALCOHOL TEST Saliva

Test rapido per la determinazione del tasso alcolemico su saliva. The ALCOHOL-Screen Saliva test can be used any time, any place. Each strip test is

individually wrapped and completely disposable. Alcohol detection using a saliva sample can be more sensitive and accurate.

360006 50 Strip

ALCOHOL TEST Urina

Test rapido per la determinazione del tasso alcolemico su campioni di urina. The ALCOHOL-Screen Urine test can be used any time, any place. Each strip test is

individually wrapped and completely disposable. Alcohol detection using a urine sample can be more sensitive and accurate. Detection Limit: 40 mg/dL ( 0,04 g/dL )

101036 50 Strip

TOX/See™ Rapid Urine

- Test rapido per la rilevazione qualitativa di droghe e loro metaboliti nell'urina umana. 1 Parametro. A One-Step Urine Test for Rapid Drug Screen

194-XXXX 25 Card

Per richiedere l'elenco completo dei test singoli, contatta l'ufficio Meridian Healthcare For further information, please contact the Meridian Healthcare office nearest

(6)

PRODUCT NAME

REF

PACKAGING

TDM-THERAPEUTIC DRUG MONITORING

CARBAMAZEPINE

latex-enhanced immunoturbidimetric assay. 939010 R1: 2x12 mL R2: 2x5 mL

DIGOSSINA

latex-enhanced immunoturbidimetric assay. 939020 R1: 2x8 mL + R2: 2x6 mL

PHENOBARBITAL

latex-enhanced immunoturbidimetric assay. 939040 R1: 2x17 mL + R2: 2x6 mL

PHENYTOIN

latex-enhanced immunoturbidimetric assay. 939050 R1: 2x17 mL + R2: 2x6 mL

VALPROIC ACID

latex-enhanced immunoturbidimetric assay. 939070 R1: 2x12 mL + R2: 2x5 mL

CONTROL & CALIBRATOR

TDM

Therapeutic Drug Calibrator 969510 6x3 mL

TDM

Therapeutic Drug Control 939550 3x5 mL
(7)

CERTIFICAZIONI

Tutti i test presenti in questo catalogo sono certificati CE e soddisfanno tutte le disposizioni della direttiva

98/79/CE e successive modifiche ed integrazioni che la riguardano - salvo diversamente indicato.

CE marking of In Vitro Diagnostic Medical

Devices - IVDD (98/79/EC)

According to the IVDD, in vitro diagnostic medical devices include: reagents, reagent products, calibration materials,

control materials, kits, instruments, apparatus, equipment, and systems that are intended for use in the

examination of specimens taken from the human body (tissue, blood, urine, etc.) to diagnose diseases, to monitor a

person’s state of health, or to monitor therapeutic procedures.

(8)

Italy Corporate Headquarter Meridian Healthcare Via G. Guglielmino, 68 Technical Support Engineering Department Meridian Healthcare Tel: +39 095 419 88 61

References

Related documents

Specifically, we use performance counters that identify on- and off-chip traffic due to coherence activity (when data for a cache miss is sourced from another core) and combine

Digital edition RELEASES PROMOTIONS NEWSLETTER DIGITAL MAGAZINE SPONSORED SECTIONS FEATURES INTERVIEWS DOWNLOADABLE

This document may contain summarised information or information that has not been audited, as well as information relative to solvency produced with criteria that are still subject

'Claims on Other Financial Corps., Depository Corporations (MYR M) SA' 'Malaysia ratio of General Provisions to Net Loans' 'Exchange Rate Volatility (eop)' 'Stock Market

This paper examines the validity of both the short-run and long-run purchasing power parity (PPP) hypotheses in Japan using two estimation methods, namely, a unit root test and

There was clearly a large difference in the structure of both apprenticeship systems, but common factors still arose, the main one being the choice and quality of the employer to

The paper likewise identified that the two organisations could benefit more from each other competencies: the EU has solid expertise on resilience of critical

[r]